SET7/9 interacts and methylates the ribosomal protein, eL42 and regulates protein synthesis.


Journal

Biochimica et biophysica acta. Molecular cell research
ISSN: 1879-2596
Titre abrégé: Biochim Biophys Acta Mol Cell Res
Pays: Netherlands
ID NLM: 101731731

Informations de publication

Date de publication:
02 2020
Historique:
received: 24 07 2019
revised: 21 10 2019
accepted: 13 11 2019
pubmed: 22 11 2019
medline: 21 4 2020
entrez: 22 11 2019
Statut: ppublish

Résumé

Methylation of proteins is emerging to be an important regulator of protein function. SET7/9, a protein lysine methyltransferase, catalyses methylation of several proteins involved in diverse biological processes. SET7/9-mediated methylation often regulates the stability, sub-cellular localization and protein-protein interactions of its substrate proteins. Here, we aimed to identify novel biological processes regulated by SET7/9 by identifying new interaction partners. For this we used yeast two-hybrid screening and identified the large subunit ribosomal protein, eL42 as a potential interactor of SET7/9. We confirmed the SET7/9-eL42 interaction by co-immunoprecipitation and GST pulldown studies. The N-terminal MORN domain of SET7/9 is essential for its interaction with eL42. Importantly, we identified that SET7/9 methylates eL42 at three different lysines - Lys53, Lys80 and Lys100 through site-directed mutagenesis. By puromycin incorporation assay, we find that SET7/9-mediated methylation of eL42 affects global translation. This study identifies a new role of the functionally versatile SET7/9 lysine methyltransferase in the regulation of global protein synthesis.

Identifiants

pubmed: 31751593
pii: S0167-4889(19)30219-8
doi: 10.1016/j.bbamcr.2019.118611
pii:
doi:

Substances chimiques

Protein Subunits 0
RNA, Small Interfering 0
RPL36A protein, human 0
Ribosomal Proteins 0
Histone-Lysine N-Methyltransferase EC 2.1.1.43
SETD7 protein, human EC 2.1.1.43
Lysine K3Z4F929H6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

118611

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Arun Mahesh (A)

Department of Biotechnology, Pondicherry University, Puducherry 605 014, India.

Mohd Imran K Khan (MIK)

Department of Biotechnology, Pondicherry University, Puducherry 605 014, India.

Gayathri Govindaraju (G)

Interdisciplinary Biology, Rajiv Gandhi Centre for Biotechnology, Trivandrum 695 014, India.

Mamta Verma (M)

Department of Biotechnology, Pondicherry University, Puducherry 605 014, India.

Sharad Awasthi (S)

Department of Biotechnology, Pondicherry University, Puducherry 605 014, India.

Pavithra L Chavali (PL)

CSIR-Centre for Cellular & Molecular Biology, Hyderabad 500 007, India.

Sreenivas Chavali (S)

Department of Biology, Indian Institute of Science Education and Research (IISER) Tirupati, Tirupati 517 507, India.

Arumugam Rajavelu (A)

Interdisciplinary Biology, Rajiv Gandhi Centre for Biotechnology, Trivandrum 695 014, India. Electronic address: arajavelu@rgcb.res.in.

Arunkumar Dhayalan (A)

Department of Biotechnology, Pondicherry University, Puducherry 605 014, India. Electronic address: arun.dbt@pondiuni.edu.in.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH